Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 23Recruiting 8Terminated 4Active not recruiting 3Unknown 2Suspended 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neuroblastoma 1Melanoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hepatitis 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Colitis 1Advanced Glioblastoma 1

Interventions

fludarabine 3Cyclophosphamide 3luspatercept 2Busulfan 2venetoclax 1trametinib 1gilteritinib 1dabrafenib 1Whole-Body Irradiation 1Vancomycin 1Thiotepa 1Teicoplanin 1Tacrolimus 1Stem Cell Transplantation 1Rituximab 1Radiosurgery 1Ofloxacin 1NF protocol 1Mycophenolic Acid 1Metronidazole 1Meropenem 1Kidney Transplantation 1Granulocyte Colony-Stimulating Factor 1Genetic Testing 1Erythropoietin 1Cytarabine 1Complementary Therapies 1Ciprofloxacin 1Ceftazidime 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hematologic Neoplasms × Mycophenolic Acid × Clear all
NCT07524530 2026-06-05

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡